Silence Therapeutics plc·4

Aug 4, 8:03 AM ET

Griffiths Richard Ian 4

4 · Silence Therapeutics plc · Filed Aug 4, 2025

Insider Transaction Report

Form 4
Period: 2025-07-31
Transactions
  • Purchase

    American Depositary Shares

    2025-08-01+4,03411,825,861 total(indirect: See footnote)
    Exercise: $6.14Ordinary Shares (12,102 underlying)
  • Purchase

    American Depositary Shares

    2025-07-31+14,34211,821,827 total(indirect: See footnote)
    Exercise: $6.18Ordinary Shares (43,026 underlying)
Footnotes (2)
  • [F1]Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.
  • [F2]The securities are held by Cream Capital Limited ("Cream"). Mr. Griffiths is a director and the controlling shareholder of Cream. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.

Documents

1 file
  • 4
    tm2522470-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT